Matches in Nanopublications for { ?s ?p "[In summary, our findings demonstrate that hMOF participates in human hepatocellular carcinoma by targeting SIRT6, and hMOF activators may serve as potential drug candidates for hepatocellular carcinoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion description "[In summary, our findings demonstrate that hMOF participates in human hepatocellular carcinoma by targeting SIRT6, and hMOF activators may serve as potential drug candidates for hepatocellular carcinoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_provenance.
- NP906634.RA7NZ0a-RSjaVGh7iU8rP0QhBF2uCmh-Na6Ps2_Xb2Xhs130_assertion description "[In summary, our findings demonstrate that hMOF participates in human hepatocellular carcinoma by targeting SIRT6, and hMOF activators may serve as potential drug candidates for hepatocellular carcinoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906634.RA7NZ0a-RSjaVGh7iU8rP0QhBF2uCmh-Na6Ps2_Xb2Xhs130_provenance.